| P2093 | author name string | Li Zhang | |
| | Feng Yang | |
| | Jianhua Zhu | |
| | Min Jin | |
| | Qingzhong Xiao | |
| | Qishan Chen | |
| P2860 | cites work | Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling | Q47689201 |
| | IL-17 stimulates migration of carotid artery vascular smooth muscle cells in an MMP-9 dependent manner via p38 MAPK and ERK1/2-dependent NF-kappaB and AP-1 activation | Q47912230 |
| | Expression of membrane-type matrix metalloproteinase in rabbit neointimal tissue and its correlation with matrix-metalloproteinase-2 activation | Q48040095 |
| | Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation: impact on restenosis | Q24294832 |
| | Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase | Q24318760 |
| | The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family | Q24557562 |
| | Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand | Q24644662 |
| | Collagenolytic activity in amphibian tissues: a tissue culture assay | Q24648397 |
| | Effect of lumican on the migration of human mesenchymal stem cells and endothelial progenitor cells: involvement of matrix metalloproteinase-14 | Q27333560 |
| | A perivascular origin for mesenchymal stem cells in multiple human organs | Q28131808 |
| | Matrix metalloproteinases: fold and function of their catalytic domains | Q28241713 |
| | FoxO4 regulates tumor necrosis factor alpha-directed smooth muscle cell migration by activating matrix metalloproteinase 9 gene transcription | Q28566755 |
| | Induction of matrix metalloproteinase-2 enhances systemic arterial contraction after hypoxia | Q28569035 |
| | Interleukin-lβ induces migration of rat arterial smooth muscle cells through a mechanism involving increased matrix metalloproteinase-2 activity | Q28576629 |
| | The role of the matrix metalloproteinases during in vitro vessel formation | Q28611471 |
| | Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9 | Q28616929 |
| | Interstitial flow promotes vascular fibroblast, myofibroblast, and smooth muscle cell motility in 3-D collagen I via upregulation of MMP-1 | Q29347013 |
| | Interstitial flow induces MMP-1 expression and vascular SMC migration in collagen I gels via an ERK1/2-dependent and c-Jun-mediated mechanism | Q29347072 |
| | Molecular mechanisms and clinical applications of angiogenesis | Q29547314 |
| | Molecular regulation of vessel maturation | Q29614540 |
| | Angiogenesis in health and disease | Q29614541 |
| | Basic and therapeutic aspects of angiogenesis | Q29615219 |
| | Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry | Q29618605 |
| | The many roles of chemokines and chemokine receptors in inflammation | Q29618880 |
| | How matrix metalloproteinases regulate cell behavior | Q29620360 |
| | Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells | Q30441514 |
| | Functional interplay between endothelial nitric oxide synthase and membrane type 1 matrix metalloproteinase in migrating endothelial cells | Q30480215 |
| | Endothelial cell lumen and vascular guidance tunnel formation requires MT1-MMP-dependent proteolysis in 3-dimensional collagen matrices | Q30488978 |
| | Mechanisms underlying the impairment of ischemia-induced neovascularization in matrix metalloproteinase 2-deficient mice | Q33275480 |
| | Cleavage and functional loss of human apolipoprotein E by digestion of matrix metalloproteinase-14. | Q33355065 |
| | Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells | Q33450208 |
| | An MT1-MMP-PDGF receptor-beta axis regulates mural cell investment of the microvasculature | Q33751487 |
| | MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis | Q33906860 |
| | LRP: role in vascular wall integrity and protection from atherosclerosis | Q34190034 |
| | Roles of PDGF in animal development | Q34227429 |
| | Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells | Q34257800 |
| | Functional role of matrix metalloproteinase-8 in stem/progenitor cell migration and their recruitment into atherosclerotic lesions. | Q50489152 |
| | MMP-2 Mediates Angiotensin II–Induced Hypertension Under the Transcriptional Control of MMP-7 and TACE | Q50554929 |
| | Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor. | Q51143587 |
| | Elevated matrix metalloproteinase expression after stent implantation is associated with restenosis. | Q51312971 |
| | Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. | Q52548108 |
| | Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells. | Q52855250 |
| | Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. | Q53606830 |
| | A proteomic approach to identify substrates of matrix metalloproteinase-14 in human plasma. | Q53633793 |
| | Important role of the angiotensin II pathway in producing matrix metalloproteinase-9 in human thoracic aortic aneurysms. | Q54459017 |
| | MT1-MMP promotes vascular smooth muscle dedifferentiation through LRP1 processing. | Q54782284 |
| | Phagocytic NADPH Oxidase-Dependent Superoxide Production Stimulates Matrix Metalloproteinase-9 | Q59623212 |
| | Opposite effects of high glucose on MMP-2 and TIMP-2 in human endothelial cells | Q60595341 |
| | Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension | Q61895228 |
| | Matrix Metalloproteinase (MMP)-3 Activates MMP-9 Mediated Vascular Smooth Muscle Cell Migration and Neointima Formation in Mice | Q63915756 |
| | Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells | Q64379249 |
| | Crucial role of membrane type 1 matrix metalloproteinase (MT1- MMP) in RhoA/Rac1-dependent signaling pathways in thrombin- stimulated endothelial cells | Q64379708 |
| | The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-kappa B | Q70824259 |
| | Transmural pressure induces matrix-degrading activity in porcine arteries ex vivo | Q73188770 |
| | Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery | Q73254515 |
| | Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model | Q73265468 |
| | The role of protein-tyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells | Q73515090 |
| | Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia | Q73854485 |
| | Increased expression of membrane-type matrix metalloproteinase and preferential localization of matrix metalloproteinase-2 to the neointima of balloon-injured rat carotid arteries | Q74093557 |
| | Reduced angiogenesis and tumor progression in gelatinase A-deficient mice | Q74309789 |
| | Characterization of the role of the "MT-loop": an eight-amino acid insertion specific to progelatinase A (MMP2) activating membrane-type matrix metalloproteinases | Q74509484 |
| | MT1-MMP, but not secreted MMPs, influences the migration of human microvascular endothelial cells in 3-dimensional collagen gels | Q74720760 |
| | MMP-7 (matrilysin) accelerated growth of human umbilical vein endothelial cells | Q77542083 |
| | Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury | Q78460679 |
| | Involvement of integrins, MAPK, and NF-kappaB in regulation of the shear stress-induced MMP-9 expression in endothelial cells | Q79437916 |
| | Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis | Q80845141 |
| | Hypoxia of endothelial cells leads to MMP-2-dependent survival and death | Q81321980 |
| | MMP-9 and -12 cause N-cadherin shedding and thereby beta-catenin signalling and vascular smooth muscle cell proliferation | Q82284786 |
| | Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin | Q82915890 |
| | Involvement of matrix metalloproteinase-2 in medial hypertrophy of pulmonary arterioles in broiler chickens with pulmonary arterial hypertension | Q83538631 |
| | Matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases regulate human aortic smooth muscle cell migration during in vitro aging | Q83978407 |
| | Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12 | Q84309344 |
| | Activation of matrix metalloproteinase-9 is associated with mobilization of bone marrow-derived cells after coronary stent implantation | Q84963515 |
| | Effects of matrix metalloproteinase-1 on the myogenic differentiation of bone marrow-derived mesenchymal stem cells in vitro | Q85239941 |
| | An important role of matrix metalloproteinase-8 in angiogenesis in vitro and in vivo | Q86434879 |
| | Low density lipoprotein receptor-related protein mediates apolipoprotein E inhibition of smooth muscle cell migration. | Q38294069 |
| | NOX4 mediates activation of FoxO3a and matrix metalloproteinase-2 expression by urotensin-II | Q39124068 |
| | Role of MT1-MMP in estrogen-mediated cellular processes of intimal hyperplasia | Q39726291 |
| | Early increased MT1-MMP expression and late MMP-2 and MMP-9 activity during Angiotensin II induced aneurysm formation | Q39756130 |
| | A role of matrix metalloproteinase-8 in atherosclerosis | Q40000765 |
| | Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation | Q40736944 |
| | The emerging concept of vascular remodeling | Q40740827 |
| | Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase | Q40887026 |
| | Activation mechanisms of matrix metalloproteinases. | Q41482018 |
| | Increased expression of Nox1 in neointimal smooth muscle cells promotes activation of matrix metalloproteinase-9. | Q42186142 |
| | Regulation of vascular smooth muscle cell expression and function of matrix metalloproteinases is mediated by estrogen and progesterone exposure | Q42442551 |
| | Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization | Q42741392 |
| | Different activation forms of MMP-2 oppositely affect the fate of endothelial cells | Q43195169 |
| | Homocysteine modulates the proteolytic potential of human arterial smooth muscle cells through a reactive oxygen species dependant mechanism | Q43269924 |
| | Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress | Q43649151 |
| | Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling | Q43670946 |
| | Activation of MMP8 and MMP13 by angiotensin II correlates to severe intra-plaque hemorrhages and collagen breakdown in atherosclerotic lesions with a vulnerable phenotype | Q43975299 |
| | MMP-3 (5A/6A) polymorphism does not influence human smooth muscle cell invasion | Q44231162 |
| | Mechanical Stretch Enhances mRNA Expression and Proenzyme Release of Matrix Metalloproteinase-2 (MMP-2) via NAD(P)H Oxidase–Derived Reactive Oxygen Species | Q44443254 |
| | Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins. | Q44456620 |
| | High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. | Q44474834 |
| | Apolipoprotein E binding to low density lipoprotein receptor-related protein-1 inhibits cell migration via activation of cAMP-dependent protein kinase A. | Q44511121 |
| | Matrix Metalloproteinase-2 and −9 Differentially Regulate Smooth Muscle Cell Migration and Cell-Mediated Collagen Organization | Q44612994 |
| | Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells | Q44631572 |
| | Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. | Q44995477 |
| | Angiotensin II induces MMP-2 in a p47phox-dependent manner | Q45238311 |
| | Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension | Q46106295 |
| | Estrogen deficiency-induced alterations of vascular MMP-2, MT1-MMP, and TIMP-2 in ovariectomized rats. | Q46235331 |
| | Chronic hypoxia accelerates the progression of atherosclerosis in apolipoprotein E-knockout mice | Q46938472 |
| | Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. | Q34542211 |
| | Adult bone marrow stem cells for cell and gene therapies: implications for greater use. | Q34669002 |
| | Inward remodeling of resistance arteries requires reactive oxygen species-dependent activation of matrix metalloproteinases | Q35056901 |
| | Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats | Q35085406 |
| | Pulsatile ex vivo perfusion of human saphenous vein grafts under controlled pressure conditions increases MMP-2 expression | Q35141088 |
| | Mechanisms of cardiovascular remodeling in hyperhomocysteinemia | Q35173832 |
| | Matrix metalloproteinases as modulators of inflammation and innate immunity | Q35852281 |
| | Bone marrow stromal cells stimulate an angiogenic program that requires endothelial MT1-MMP. | Q35918685 |
| | Chemokines in the pathogenesis of vascular disease | Q35932790 |
| | Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease | Q36009930 |
| | Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. | Q36240875 |
| | Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates | Q36305029 |
| | Smoking, metalloproteinases, and vascular disease | Q36336918 |
| | MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells. | Q36402867 |
| | Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease | Q36477722 |
| | Matrix metalloproteinase-1-mediated up-regulation of vascular endothelial growth factor-2 in endothelial cells | Q36508733 |
| | Role of matrix metalloproteinase-8 in atherosclerosis | Q36567357 |
| | Angiogenesis and chronic inflammation: cause or consequence? | Q36801097 |
| | Keratinocyte expression of MMP3 enhances differentiation and prevents tumor establishment | Q36943114 |
| | Prolonged increases in vein wall tension increase matrix metalloproteinases and decrease constriction in rat vena cava: Potential implications in varicose veins | Q36953739 |
| | NADPH oxidase 2 regulates bone marrow microenvironment following hindlimb ischemia: role in reparative mobilization of progenitor cells. | Q36987722 |
| | Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis | Q37061090 |
| | Matrix metalloproteinase-1 promotes muscle cell migration and differentiation | Q37071885 |
| | Hypoxia and placental remodelling. | Q37082653 |
| | Transgenic expression of human matrix metalloproteinase-1 attenuates pulmonary arterial hypertension in mice | Q37100777 |
| | Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2. | Q37195371 |
| | Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3. | Q37276960 |
| | Inflammatory cytokines in vascular dysfunction and vascular disease | Q37315106 |
| | Inflammation, growth factors, and pulmonary vascular remodeling | Q37531255 |
| | Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. | Q37561940 |
| | Emerging biology of vascular wall progenitor cells in health and disease | Q37614679 |
| | Hypoxia-driven angiogenesis: role of tip cells and extracellular matrix scaffolding. | Q37716522 |
| | Matrix metalloproteinase inhibition therapy for vascular diseases | Q37983293 |
| | Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases. | Q38004039 |
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | enzyme | Q8047 |
| P304 | page(s) | 928315 | |
| P577 | publication date | 2013-06-12 | |
| P1433 | published in | Mediators of Inflammation | Q2144494 |
| P1476 | title | Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling | |
| P478 | volume | 2013 | |